Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation.

Journal of medicinal chemistry·2026
Same author

Application of protein language models for antibody developability prediction.

mAbs·2026
Same author

Modulating AP-1 enables CAR T cells to establish an intratumoral stemlike reservoir and overcomes resistance to PD-1 blockade.

Science immunology·2026
Same author

Identification of aryl hydrocarbon receptor as a functional target that enhances astrocytic ApoE secretion.

Cell chemical biology·2026
Same author

Correction to "ROSHAMBO2: Accelerating Molecular Alignment for Large Chemical Libraries with GPU Optimization and Algorithmic Advances".

Journal of chemical information and modeling·2026
Same author

ROSHAMBO2: Accelerating Molecular Alignment for Large Chemical Libraries with GPU Optimization and Algorithmic Advances.

Journal of chemical information and modeling·2025
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same journal

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.

Simone Sciabola1, Robert V Stanton, Sarah Wittkopp

  • 1Laboratorio di Chemiometria, Universitá di Perugia, Via Elce di Sotto, 10, 1-06123, Perugia, Italy. simone.sciabola@pfizer.com

Journal of Chemical Information and Modeling
|August 23, 2008
PubMed
Summary
This summary is machine-generated.

Quantitative structure activity relationship (QSAR) models predict kinase inhibitor selectivity using experimental data. These models help understand structure-selectivity relationships for improved drug design.

More Related Videos

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 2, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Pharmacology

Background:

  • Kinases play crucial roles in diseases like cancer, diabetes, and arthritis.
  • Kinase small molecule inhibitors are promising therapeutic agents.
  • Achieving selectivity in kinase inhibitor design remains a significant challenge.

Purpose of the Study:

  • To apply in silico quantitative structure activity relationship (QSAR) models for predicting kinase inhibitor selectivity.
  • To extract predictive rules from a panel of 45 in-house kinase assays.
  • To develop R-group selectivity profiles for enhanced understanding of structure-selectivity relationships.

Main Methods:

  • Development of in-house kinase assays (45 assays).
  • Application of in silico quantitative structure activity relationship (QSAR) models.
  • Enumeration of compounds from virtual libraries for prediction.
  • Construction of R-group selectivity profiles.

Main Results:

  • QSAR models successfully extracted rules from experimental screening data.
  • Reliable selectivity profile predictions were made for virtual library compounds.
  • R-group selectivity profiles provided insights into kinase activity contributions.

Conclusions:

  • In silico QSAR models are effective tools for predicting kinase inhibitor selectivity.
  • R-group selectivity profiles enhance the understanding of subtle structure-selectivity relationships.
  • These approaches aid in the rational design of more selective kinase inhibitors.